693785-69-2

Upstream product

• 109183-71-3 N-(tert-butoxycarbonyl)-L-cyclohexylglycine 
• 13734-41-3 t-Boc-L-valine 
• 220424-87-3 Boc-Val-Pro-(4R)-(1-naphthylmethoxy) allyl ester 
• 220424-78-2 (4R)-1-(tert-butoxycarbonyl)-4-(1-naphthylmethoxy)-L-proline allyl ester 
• 220424-74-8 (4R)-1-(tert-butoxycarbonyl)-4-(1-naphthylmethoxy)-L-proline 
• 3163-27-7 2-(bromomethyl)naphthalene 
• 13726-69-7 (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid 

Downstream Products

• 693785-71-6 1-{[(2S,4R)-1-[(S)-2-((S)-2-Acetylamino-2-cyclohexyl-acetylamino)-3-methyl-butyryl]-4-(naphthalen-1-ylmethoxy)-pyrrolidine-2-carbonyl]-amino}-2-ethyl-cyclopropanecarboxylic acid methyl ester 
• 693785-70-5 Ac-Chg-Val-Pro-(4R)-(1-naphthylmethoxy) allyl ester 

Relevant academic research and scientific papers

Peptide-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Structure-Activity Relationship at the C-Terminal Position

The structure-activity relationship at the C-terminal position of peptide-based inhibitors of the hepatitis C virus NS3 protease is presented. The observation that the N-terminal cleavage product (DDIVPC-OH) of a substrate derived from the NS5A/5B cleavag